What kind of drug is Letairis (ambrisentan)? A detailed pharmacological overview
•
4 min read
According to the Pulmonary Hypertension Association, Letairis (ambrisentan) is a key oral medication approved by the FDA for the treatment of pulmonary arterial hypertension (PAH). This powerful medication falls under the drug class of selective endothelin receptor antagonists, working to improve exercise ability and delay clinical worsening in adult patients.
